What is Anebulo Pharmaceuticals Inc (ANEB) stock price today?

Anebulo Pharmaceuticals Inc (ANEB) currently trades at $0.43 per share. The stock has a market capitalization of $22.43M and a P/E ratio of —x.

Is ANEB stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Anebulo Pharmaceuticals Inc has a Smart Value Score of 25/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is —.

Is Anebulo Pharmaceuticals Inc financially healthy?

Anebulo Pharmaceuticals Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of — places it in the —.

ANEB

Anebulo Pharmaceuticals Inc

NASDAQ: ANEB · HEALTHCARE · BIOTECHNOLOGY

$0.43

-11.78% today

Updated 2026-04-29

Market cap

$22.43M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.18

Dividend yield

—

52W range

$0 – $3

Volume

0.0M

Market cap

$22.43M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.18

Dividend yield

—

52W range

$0 – $3

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$3.00

+603.73%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-1.31M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-6.83M	$-11.73M	$-8.20M	$-8.48M	$-2.00M
EPS	—	—	—	—	$-0.18
Free cash flow	$-5.44M	$-9.68M	$-8.09M	$-6.35M	$-1.31M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ANEB	$22.43M	25	4.3	3.0	5.0	6.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Anebulo Pharmaceuticals Inc trades at $0.43. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score.

Frequently asked questions

What is Anebulo Pharmaceuticals Inc's stock price?

Anebulo Pharmaceuticals Inc (ANEB) trades at $0.43.

Is Anebulo Pharmaceuticals Inc overvalued?

Smart Value Score 25/100 (Grade F, Strong Sell).

What is the price target of Anebulo Pharmaceuticals Inc (ANEB)?

The analyst target price is $3.00, representing +603.7% upside from the current price of $0.43.

Piotroski F-Score?

3/9 — weak financial health.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-0.70%

Beta-0.70

50D MA$0.76

200D MA$1.82

Shares out0.04B

Float0.00B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ANEB vs LLY →ANEB vs JNJ →ANEB vs ABBV →Stock screener →